A detailed history of Davenport & CO LLC transactions in Viatris Inc stock. As of the latest transaction made, Davenport & CO LLC holds 14,201 shares of VTRS stock, worth $165,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,201
Previous 12,032 18.03%
Holding current value
$165,583
Previous $143,000 4.9%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$10.05 - $12.02 $21,798 - $26,071
2,169 Added 18.03%
14,201 $150,000
Q1 2024

May 03, 2024

BUY
$11.27 - $13.53 $135,600 - $162,792
12,032 New
12,032 $143,000
Q3 2023

Oct 17, 2023

SELL
$9.59 - $11.35 $34,782 - $41,166
-3,627 Reduced 21.28%
13,417 $132,000
Q2 2023

Jul 20, 2023

SELL
$9.02 - $10.29 $78,997 - $90,119
-8,758 Reduced 33.94%
17,044 $170,000
Q1 2023

Apr 27, 2023

SELL
$9.2 - $12.26 $39,514 - $52,656
-4,295 Reduced 14.27%
25,802 $248,000
Q4 2022

Jan 20, 2023

SELL
$8.72 - $11.56 $9,583 - $12,704
-1,099 Reduced 3.52%
30,097 $0
Q3 2022

Oct 11, 2022

SELL
$8.48 - $11.13 $32,130 - $42,171
-3,789 Reduced 10.83%
31,196 $266,000
Q2 2022

Jul 18, 2022

SELL
$9.95 - $12.27 $36,824 - $45,411
-3,701 Reduced 9.57%
34,985 $366,000
Q1 2022

May 02, 2022

SELL
$9.81 - $15.4 $3,511 - $5,513
-358 Reduced 0.92%
38,686 $421,000
Q4 2021

Feb 10, 2022

SELL
$12.09 - $14.68 $52,518 - $63,769
-4,344 Reduced 10.01%
39,044 $528,000
Q3 2021

Oct 14, 2021

SELL
$13.25 - $15.13 $6,704 - $7,655
-506 Reduced 1.15%
43,388 $588,000
Q2 2021

Jul 28, 2021

BUY
$12.97 - $16.15 $151,515 - $188,664
11,682 Added 36.27%
43,894 $627,000
Q1 2021

Apr 28, 2021

SELL
$13.59 - $18.54 $192,149 - $262,137
-14,139 Reduced 30.5%
32,212 $450,000
Q4 2020

Jan 13, 2021

BUY
$14.3 - $18.74 $662,819 - $868,617
46,351 New
46,351 $869,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.